Pharmacovigilance and Drug Safety Software Market Competitive Landscape, Growth Factors, Revenue Analysis By 2028

The pharmacovigilance and drug safety software market is estimated to be valued at USD 165.08 million in 2021. It is expected to reach approximately USD 238.68 million in 2027, registering a CAGR of nearly 6.49% during the forecast period. The growing availability of data, the need to process & derive insights from the generated data, stringent reporting norms & standards, and increasing software upgrades by key companies are some of the key drivers of this market. INTIENT Pharmacovigilance by Accenture is a comprehensive product suite that helps in the collection and management of a full spectrum of pharmacovigilance data.

Major Players

• Ennov Solutions Inc.
• Extedo GmbH
• United BioSource Corporation
• Ab Cube
• ArisGlobal

 The following segmentation are covered in this report:

By Functionality

• Adverse Event Reporting Software
• Drug Safety Audits Software
• Issue Tracking Software
• Fully Integrated Software

By Mode of Delivery

• On-premise Delivery
• On-demand/ Cloud-based (SaaS) Delivery

By End Users

• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Business Process Outsourcing Firms
• Other Pharmacovigilance Service Providers

Scope of the report

The research study analyses the Pharmacovigilance and Drug Safety Software Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Pharmacovigilance and Drug Safety Software Market Report

• What was the Pharmacovigilance and Drug Safety Software Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Pharmacovigilance and Drug Safety Software Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.